Results 251 to 260 of about 531,523 (312)
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Concurrent jamming and mesenchymal-to-epithelial transitions during airway basal stem cell differentiation. [PDF]
Mitchel JA +8 more
europepmc +1 more source
Restructuring breeding programs 1: Integration of diversity. [PDF]
Niehoff TAM, Ten Napel J, Calus MPL.
europepmc +1 more source
Heterogeneity of estrogen and β-adrenergic receptors in female human coronary artery endothelial cells. [PDF]
Elsaid B +4 more
europepmc +1 more source
Genome-wide association study identifies protective genetic factors in active blood donors against multiple diseases. [PDF]
Clancy J +7 more
europepmc +1 more source
Latent iron deficiency as a silent driver of donor attrition in high-frequency plateletpheresis donors: a longitudinal cohort study. [PDF]
Jin L +6 more
europepmc +1 more source
Activation of Thioglycosides with Ferric Chloride: Scope and Mechanism. [PDF]
Ridgway LM +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Recent progress on donor and donor–donor carbenes
Chemical Society Reviews, 2020This review highlights the recent advances in donor and donor–donor carbenes.
Dong Zhu +4 more
openaire +2 more sources

